The development of inhibitors of LRRK2 as a therapeutic strategy for Parkinson's disease: the current state of play.
Current therapeutic approaches for Parkinson's disease (PD) are based around treatments that alleviate symptoms but do not slow or prevent disease progression. As such, alternative strategie...